Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Dr Meghan Morrissey’s research uses cell and synthetic biology to uncover basic principles of macrophage signalling with an eye toward designing new therapeutics. Macrophages, key effectors of the innate immune system, protect the body by phagocytosing harmful targets while robustly ignoring healthy cells. Macrophages measure and integrate the signals they encounter to decide what to eat. These signals also tell macrophages if they should adjust their appetite, and what information to relay other immune cells. The mechanistic insight from our studies is critical for immunoengineering, or controlled activation of the immune system. We are particularly interested in how to control macrophage signalling during cancer therapy. Dr Morrissey is an Assistant Professor at the University of California Santa Barbara. Prior to joining UCSB in 2020, Dr Morrissey was a postdoctoral fellow at University of California San Francisco in Ron Vale’s lab. She obtained her PhD from Duke University in 2015 and her BS from the University of Notre Dame in 2009.
